Evidence map›Paper›PMID 23572277›Full record

ArticlePathology oncology research : POR2013

Expression of secreted frizzled-related protein 1 and 3, T-cell factor 1 and lymphoid enhancer factor 1 in clear cell renal cell carcinoma.

Tamara Nikuševa-Martić, Ljiljana Serman, Martina Zeljko, Zeljko Vidas, Slavko Gašparov, Hrvojka Marija Zeljko, Marin Kosović, Nives Pećina-Šlaus

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Wnt signaling in kidney: the initiator or terminator?Journal of molecular medicine (Berlin, Germany) · 2020
    Review
  6. Article
  7. Clinical Significance of Transcription Factor 7 (TCF7) as a Prognostic Factor in Gastric Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tamara Nikuševa-MartićDepartment of Biology, School of Medicine, University of Zagreb, Šalata 3, 10000 Zagreb, Croatia. tmartic@mef.hr
Ljiljana Serman
Martina Zeljko
Zeljko Vidas
Slavko Gašparov
Hrvojka Marija Zeljko
Marin Kosović
Nives Pećina-Šlaus
Klinička bolnica Merkur · HRUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frequency and mortality of renal cell carcinoma (RCC) are increasing for decades. However, the molecular background of RCC tumorigenesis is still poorly understood. In current study we investigated the expression of TCF/LEF and SFRP family members (SFRP1 and SFRP3) to gain a better understanding of biological signaling pathways responsible for epidemiology and clinical parameters of clear cell RCC (cRCC). Thirty-six pairs of paraffin-embedded clear cRCC and adjacent nontumoral tissues samples using immunohistochemistry (IHC) were analyzed and compared with corresponding clinicopathological parameters. Immunohistochemistry indicated statistically significant decreased SFRP3 expression in tumor tissues but no consistency in SFRP1 expression in analyzed normal and tumor tissue. The TCF1 expression level was significantly weaker in normal tissue compared to tumor samples while LEF1 protein levels were significantly weaker in tumor tissue. To our knowledge, this is the first report on analysis of the expression of transcription factors TCF1 and LEF1 in clear cell renal cell carcinoma and their comparison with Wnt signal pathway antagonists belonging to SFRP family.

Indexed as

AdultAgedAnalysis of VarianceCarcinoma, Renal CellFemaleFrizzled-Related ProteinsGlycoproteinsHumansImmunohistochemistryIntracellular Signaling Peptides and ProteinsKidney NeoplasmsLymphoid Enhancer-Binding Factor 1MaleMiddle AgedPrincipal Component AnalysisStatistics, NonparametricFrizzled-Related ProteinsGlycoproteinsIntracellular Signaling Peptides and ProteinsLEF1 protein, humanLymphoid Enhancer-Binding Factor 1T Cell Transcription Factor 1TCF7 protein, human

Identifiers

PMID23572277
OpenAlexW1993443102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.